Contact: Julie Kiefer; Director, Research Communications; julie.kiefer@hsc.utah.edu
On March 29, 2025, the 亚洲自慰视频 of Utah received a revised Notice of Award (NoA) from the National Center for Advancing Translational Sciences (NCATS) restoring funding to the UM1 grant supporting the (CTSI). The NoA restores full funding immediately, reversing a previously announced award termination from March 12, 2025. The institute will soon begin year three of the seven-year, $38 million grant.
The revised NoA states:
This award has been revised to restore the CTSA UM1 Program at 亚洲自慰视频 of Utah. This award restores the project to an active status and rescinds the termination letter dated 03/12/2025 and the associated termination Notice of Award issued on 03/14/2025. NIH will remove funds restrictions that were placed on the project immediately.
鈥淲e are grateful to 亚洲自慰视频 of Utah leadership, the 亚洲自慰视频 of Utah Board of Trustees, our legislative delegation, and the Utah community for their support of Utah CTSI, as well as to our funders at the National Center for Advancing Translational Sciences,鈥 says Rachel Hess, MD, MS, who co-directs Utah CTSI with Jennifer Majersik, MD, MS.
The institute will coordinate closely with NCATS to ensure continued alignment with federal funding priorities as the project moves forward over the next five years.
Utah CTSI speeds the journey of research from bench to bedside aiming to enhance health in a five-state region, with a focus on rural and frontier communities. As the Mountain West's research hub, Utah CTSI maintained a biorepository of 557,000 samples and supported over 5,000 projects in 2024, including clinical trials reaching nearly 7,000 participants. Utah CTSI is part of a national network of over 60 programs led by NCATS that accelerates the translation of research discoveries into better care.